Case Study on Pharmacovigilance Support for Vaccine Development

This case study details how Fortrea's FSPx team supported an emerging biotech in managing a 1200% increase in safety data cases during influenza vaccine development. It highlights strategic operational management, resource allocation, and the establishment of a safety database to ensure regulatory compliance and effective pharmacovigilance. The success of this partnership led to further collaboration for COVID-19 vaccine safety services, demonstrating Fortrea's role as an extended safety partner